Made in
FRANCE
Caricamento
Vai direttamente al contenuto
ingredienti naturali 🌱 prodotto in Francia 🇫🇷 vegan 🍏 packaging ecologico 🌍 efficacia provata 🩺
BALANCE è il nostro trattamento “base” per l'equilibrio ormonale
Progettato per regolare l'attività ormonale all'origine dei dolori mestruali e dei cicli irregolari
Ogni giorno
Inizia il trattamento in qualsiasi momento durante il ciclo (ciclo = 28 giorni). Assumi 2 capsule al giorno durante un pasto con un abbondante bicchiere d'acqua.
1 mese
Inizierai a vedere miglioramenti dopo un mese di utilizzo.
3 mesi
Questa è la durata minima consigliata per un riequilibrio completo e duraturo.
6 mesi
In 6 mesi i benefici sono massimizzati, l'equilibrio ormonale si stabilizza.
Ogni giorno
1 mese
3 mesi
6 mesi
Inizia il trattamento in qualsiasi momento durante il ciclo (ciclo = 28 giorni). Assumi 2 capsule al giorno durante un pasto con un abbondante bicchiere d'acqua.
Inizierai a vedere miglioramenti dopo un mese di utilizzo.
Questa è la durata minima consigliata per un riequilibrio completo e duraturo.
In 6 mesi i benefici sono massimizzati, l'equilibrio ormonale si stabilizza.
💊 1 confezione = 1 mese di utilizzo ovvero 2 capsule al giorno, da assumere durante un pasto, con un bicchiere d'acqua. Se hai difficoltà a deglutire le capsule, puoi anche cospargere il contenuto in una bevanda o in un preparato.
🕗 Quando iniziare la cura : in qualsiasi momento durante il ciclo, fino alla fine del box.
📅 Durata della cura : da 3 a 6 mesi completi. Per un riequilibrio completo e benefici a lungo termine consigliamo 3 mesi interi di trattamento, nonché l'applicazione dei consigli sullo stile di vita del nostro Metodo dei 28 Giorni. Il trattamento può essere seguito per 6 mesi per massimizzare i benefici e stabilizzare l'equilibrio ormonale, e in caso di squilibrio più profondo.
I nostri prodotti sono tutti garantiti 100% naturali, vegani, senza glutine, senza ingredienti controversi.
Elenco completo degli ingredienti:
Bisglicinato di magnesio, Estratto di radice di rodiola (Rhodiola rosea L.), Capsula vegetale (agente di rivestimento: HPMC), Polvere di frutti di agnocasto (Vitex agnus-castus L.), Estratto di foglie di Ginkgo (Ginkgo biloba L. .), Estratto di radice di Cohosh (Cimicifuga racemosa L.), vitamina B6
Contraccezione ormonale : no.
La pillola o altri contraccettivi ormonali forniscono già un equilibrio ormonale artificiale.
I sintomi come la sindrome premestruale che si possono manifestare durante l'assunzione della pillola/contraccettivo ormonale possono essere collegati agli effetti collaterali della contraccezione: per rimediare è meglio parlare con un professionista.
Pre-menopausa / Menopausa : sì.
Il rallentamento della produzione di estrogeni è all’origine dei disturbi fisici e psicologici che segnano l’avvicinarsi della menopausa. L'agnocasto e la vitamina B6 contribuiscono alla regolazione dell'attività ormonale.
Gravidanza : no.Non raccomandato per le donne incinte.
Allattamento : no.
Non raccomandato per le donne che allattano.
Se si cerca una gravidanza : sì, ma...
L'azione di riequilibrio ormonale dell'agnocasto lo rende un alleato d'elezione per combattere i cicli irregolari che possono compromettere la fertilità. Tuttavia, il trattamento dovrà essere interrotto una volta confermata la gravidanza.
In caso di PMA è da evitare BALANCE perché l'azione dell'agnocasto potrebbe interagire con i trattamenti.
Precauzioni :
- Non raccomandato per le donne con una storia personale o familiare di tumori ormono-dipendenti come il cancro al seno.
- Non raccomandato per le persone che assumono antidepressivi o anticoagulanti e per le persone con problemi al fegato.
- Non raccomandato in caso di malattie biliari o epatiche.
- Non raccomandato in caso di epilessia.
- Non raccomandato in caso di procedura interventistica invasiva pianificata.
- Le persone che seguono un trattamento farmacologico devono prima consultare un operatore sanitario.
Gli integratori alimentari non possono sostituire una dieta variata ed equilibrata e uno stile di vita sano. Non superare la dose giornaliera
raccomandata. Tenere fuori dalla portata dei bambini. Conservare al riparo dalla luce, dal calore e dall'umidità. Riservato agli adulti. Sconsigliato durante la gravidanza o l'allattamento, in caso di tumori
ormono-dipendenti o di precedenti personali o familiari di tali tumori, di tumore ipofisario a prolattina, o di precedenti di disturbi ipofisari, in caso di malattie biliari o epatiche, in caso di epilessia, in caso di assunzione di antidepressivi, in caso di assunzione di anticoagulanti e
in caso di interventi chirurgici invasivi programmati. In caso di trattamenti farmacologici, consultare un professionista della salute.
Elenco completo degli ingredienti
Magnesio
250 mg
De Souza, M. C., Walker, A. F., Robinson, P. A., & Bolland, K. (2000). A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. Journal of women's health & gender-based medicine,9(2), 131-139Ebrahimi, E., Motlagh, S. K., Nemati, S., & Tavakoli, Z. (2012). Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms. Journal of caring sciences,1(4), 183Facchinetti, F., Borella, P., Sances, G., Fioroni, L., Nappi, R. E., & Genazzani, A. R. (1991). Oral magnesium successfully relieves premenstrual mood changes. Obstetrics and Gynecology,78(2), 177-181Facchinetti, F., Sances, G., Borella, P., Genazzani, A. R., & Nappi, G. (1991). Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache: The Journal of Head and Face Pain,31(5), 298-301Fathizadeh, N., Ebrahimi, E., Valiani, M., Tavakoli, N., & Yar, M. H. (2010). Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iranian Journal of Nursing and Midwifery Research,15(Suppl1), 401Ghalwa, N. A., Qedra, R., & Wahedy, K. (2014). Impact of calcium and magnesium dietary changes on women pain and discomfort from premenstrual syndrome at the Faculty of Pharmacy-Gaza strip. World J Pharm Pharm Sci,3, 981-1005Kia, A. S., Amani, R., & Cheraghian, B. (2015). The association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among university students: a case control study. Health promotion perspectives,5(3), 225London, R. S., Bradley, L., & Chiamori, N. Y. (1991). Effect of a nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study. Journal of the American College of Nutrition,10(5), 494-499Mauskop, A., Altura, B. T., & Altura, B. M. (2002). Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache: The Journal of Head and Face Pain,42(4), 242-248Posaci, C., Erten, O., Üren, A., & Acar, B. (1994). Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta obstetricia et gynecologica Scandinavica,73(6), 452-455Quaranta, S., Buscaglia, M. A., Meroni, M. G., Colombo, E., & Cella, S. (2007). Pilot study of the efficacy and safety of a modified-release magnesium 250mg tablet (Sincromag®) for the treatment of premenstrual syndrome. Clinical drug investigation,27(1), 51-58Rosenstein, D. L., Elin, R. J., Hosseini, J. M., Grover, G., & Rubinow, D. R. (1994). Magnesium measures across the menstrual cycle in premenstrual syndrome. Biological psychiatry,35(8), 557-561Sharma, G., & Tandon, P. (2015). Luteal phase serum calcium and serum magnesium levels in causation of premenstrual syndrome. Int J Basic Appl Physiol,4(1), 126Sherwood, R. A., Rocks, B. F., Stewart, A., & Saxton, R. S. (1986). Magnesium and the premenstrual syndrome. Annals of clinical biochemistry,23(6), 667-670Stewart, A. (1987). Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. The Journal of reproductive medicine,32(6), 435-441Walker, A. F., De Souza, M. C., Vickers, M. F., Abeyasekera, S., Collins, M. L., & Trinca, L. A. (1998). Magnesium supplementation alleviates premenstrual symptoms of fluid retention. Journal of Women's health,7(9), 1157-1165Magdalena D. Cuciureanu, Robert Vink. (2011). Magnesium and stress. Magnesium in the Central Nervous System. Gisèle Pickering, André Mazur, Marion Trousselard, Przemyslaw Bienkowski, Natalia Yaltsewa, Mohamed Amessou, Lionel Noah, Etienne Pouteau. (2020). Magnesium Status and Stress: The Vicious Circle Concept Revisited. National Library of Medicine.Mario Barbagallo, Nicola Veronese, Ligia J Dominguez. (2021). Magnesium in Aging, Health and Diseases. National Library of Medicine.Neil Bernard Boyle, Clare L Lawton, Louise Dye. (2016). The effects of magnesium supplementation on subjective anxiety. National Library of Medicine.
Afficher plus
Rodiola
210 mg
Bangratz, M., Abdellah, S. A., Berlin, A., Blondeau, C., Guilbot, A., Dubourdeaux, M., & Lemoine, P. (2018). A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression. Neuropsychiatric disease and treatment,14, 1821Bystritsky, A., Kerwin, L., & Feusner, J. D. (2008). A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD). The Journal of Alternative and Complementary Medicine,14(2), 175-180Chatterjee, A., Sen, B., Das, S., & Chatterjee, T. K. (2015). Anti-inflammatory and analgesic activity of methanolic xtract of medicinal plant Rhodiola rosea rhizomes. International Journal of Pharmacolology Resesearch and Review,4(2), 1-8Chen, Q. G., Zeng, Y. S., Qu, Z. Q., Tang, J. Y., Qin, Y. J., Chung, P., ... & Hägg, U. (2009). The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine,16(9), 830-838Darbinyan, V., Kteyan, A., Panossian, A., Gabrielian, E., Wikman, G., & Wagner, H. (2000). Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine,7(5), 365-371Darbinyan, V., Aslanyan, G., Amroyan, E., Gabrielyan, E., Malmström, C., & Panossian, A. (2007). Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic journal of psychiatry,61(5), 343-348Edwards, D., Heufelder, A., & Zimmermann, A. (2012). Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms–Results of an Open‐label Study. Phytotherapy Research,26(8), 1220-1225Goyvaerts, B., & Bruhn, S. (2012). Rhodiola rosea-Spezialextrakt SHR-5 bei Burn-out und Erschöpfungssyndrom. Erfahrungsheilkunde,61(02), 79-83Kasper, S., & Dienel, A. (2017). Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms. Neuropsychiatric disease and treatment,13, 889Lee, Y., Jung, J. C., Jang, S., Kim, J., Ali, Z., Khan, I. A., & Oh, S. (2013). Anti-inflammatory and neuroprotective effects of constituents isolated from Rhodiola rosea. Evidence-based complementary and alternative medicine, 2013Lekomtseva, Y., Zhukova, I., & Tartakovsky, I. (2013). Therapy effects and safety of rhodiola rosea extract ws 1375 in subjects with symptoms of chronic fatigue. Бюллетень сибирской медицины,12(5), 73-75Lekomtseva, Y., Zhukova, I., & Wacker, A. (2017). Rhodiola rosea in subjects with prolonged or chronic fatigue symptoms: results of an open-label clinical trial. Complementary medicine research,24(1), 46-52Mao, J. J., Li, Q. S., Soeller, I., Xie, S. X., & Amsterdam, J. D. (2014). Rhodiola rosea therapy for major depressive disorder: A study protocol for a randomized, double-blind, placebo-controlled trial. Journal of clinical trials,4, 170Mao, J. J., Xie, S. X., Zee, J., Soeller, I., Li, Q. S., Rockwell, K., & Amsterdam, J. D. (2015). Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine,22(3), 394-399Mattioli, L., Funari, C., & Perfumi, M. (2009). Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. Journal of Psychopharmacology,23(2), 130-142Montiel-Ruiz, R. M., González-Trujano, M. E., & Deciga-Campos, M. (2013). Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test. Phytomedicine,20(14), 1280-1287Olsson, E. M., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta medica,75(02), 105-112Palmeri, A., Mammana, L., Tropea, M. R., Gulisano, W., & Puzzo, D. (2016). Salidroside, a bioactive compound of rhodiola rosea, ameliorates memory and emotional behavior in adult mice. Journal of Alzheimer's Disease,52(1), 65-75Perfumi, M., & Mattioli, L. (2007). Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives,21(1), 37-43Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'Skij, V. B., Korovin, Y. P., Khristich, M. P., ... & Wikman, G. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine,10(2-3), 95-105Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'Skij, V. B., Korovin, Y. P., Khristich, M. P., ... & Wikman, G. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine,10(2-3), 95-105Spasov, A. A., Wikman, G. K., Mandrikov, V. B., Mironova, I. A., & Neumoin, V. V. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine,7(2), 85-89Ion-George Anghelescu, David Edwards, Erich Seifritz, Siegfried Kasper. (2018). Stress management and the role of Rhodiola rosea: a review. National Library of Medicine.Mark Cropley, Adrian P Banks, Julia Boyle. (2015).The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. National Library of Medicine.
Afficher plus
Agnocasto
96 mg
Linlin Ma, Shouqing Lin, Rong Chen, Ying Zhang, Fengling Chen, Xiuli Wang. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol, 2010M Diana van Die, Henry G Burger, Helena J Teede, Kerry M Bone. (2013). Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. National Library of Medicine. Arezoo Moini Jazani, Hamidreza Nasimi Doost Azgomi, Alireza Nasimi Doost Azgomi, Ramin Nasimi Doost Azgomi. (2019). A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). National Library of Medicine. Maša Kenda, Nina Kočevar Glavač, Milan Nagy, Marija Sollner Dolenc, On Behalf Of The Oemonom. (2021). Herbal Products Used in Menopause and for Gynecological Disorders. National Library of Medicine.
Afficher plus
Gingko Biloba
90 mg
Alsmadi, A. M., Tawalbeh, L. I., Gammoh, O. S., Shawagfeh, M. Q., Zalloum, W., Ashour, A., & Attarian, H. (2018). The effect of Ginkgo biloba and psycho-education on stress, anxiety and fatigue among refugees. Proceedings of Singapore Healthcare, 27(1), 26-32.Johnson, S. K., Diamond, B. J., Rausch, S., Kaufman, M., Shiflett, S. C., & Graves, L. (2006). The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial. Explore, 2(1), 19-24.Kan, J., Hu, C., Chen, L., Liu, S., Venzon, D., Murray, M., ... & Du, J. (2020). A botanical product containing cistanche and ginkgo extracts improves chronic fatigue syndrome: a randomized, double-blind, placebo-controlled study.Kehr, J., Yoshitake, S., Ijiri, S., Koch, E., Nöldner, M., & Yoshitake, T. (2012). Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®. International psychogeriatrics, 24(S1), S25.Mashayekh, A., Pham, D. L., Yousem, D. M., Dizon, M., Barker, P. B., & Lin, D. D. (2011). Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology, 53(3), 185-191.Ozgoli, G., Selselei, E. A., Mojab, F., & Majd, H. A. (2009). A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. The Journal of Alternative and Complementary Medicine, 15(8), 845-851.Reay, J. L., van Schaik, P., & Wilson, C. J. (2019). A systematic review of research investigating the physiological and psychological effects of combining Ginkgo biloba and Panax ginseng into a single treatment in humans: Implications for research design and analysis. Brain and behavior, 9(3), e01217.Ribeiro, M. L., Moreira, L. M., Arçari, D. P., dos Santos, L. F., Marques, A. C., Pedrazzoli Jr, J., & Cerutti, S. M. (2016). Protective effects of chronic treatment with a standardized extract of Ginkgo biloba L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats. Behavioural Brain Research, 313, 144-150.Shi, C., Xiao, S., Liu, J., Guo, K., Wu, F., Yew, D. T., & Xu, J. (2010). Ginkgo biloba extract EGb761 protects against aging-associated mitochondrial dysfunction in platelets and hippocampi of SAMP8 mice. Platelets, 21(5), 373-379.Wesnes, K. W., Faleni, R. A., Hefting, N. R., & Hoogsteen, G. (1997). The cognitive, subjective, and physical effects of a Ginkgo biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacology Bulletin, 33(4), 677.Wesnes, K. A., Ward, T., McGinty, A., & Petrini, O. (2000). The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152(4), 353-361.Zhang, Z. J., Tong, Y., Zou, J., Chen, P. J., & Yu, D. H. (2009). Dietary supplement with a combination of Rhodiola crenulata and Ginkgo biloba enhances the endurance performance in healthy volunteers. Chinese journal of integrative medicine, 15(3), 177-183.Jacqueline Birks, John Grimley Evans. (2009). Ginkgo biloba for cognitive impairment and dementia. National Library of Medicine. Giovanni D'Andrea, Gennaro Bussone, Gianni Allais, Marco Aguggia, Florindo D'Onofrio, Maurizio Maggio, Franca Moschiano, Maria Gabriella Saracco, Maria Grazia Terzi, Vittorio Petretta, Chiara Benedetto. (2009). Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. National Library of Medicine.
Afficher plus
Cohosh nero
7,5 mg
Matthew J Leach, Vivienne Moore. (2021). Black cohosh (Cimicifuga spp.) for menopausal symptoms. National Library of Medicine.Francesca Borrelli, Edzard Ernst. (2008). Black cohosh (Cimicifuga racemosa) for menopausal symptoms: A systematic review of its efficacy. Pharmacological Research. p8-14.
Afficher plus
Vitamina B6
3,5 mg
Abraham, G. E., & Hargrove, J. T. (1981). Effect of vitamin B-6 on premenstrual symptomatology in women with premenstrual tension syndromes: a double blind crossover study. Obstetrical & Gynecological Survey, 36(5), 259-261Adams, P. W., Wynn, V., Rose, D. P., Seed, M., Folkard, J., & Strong, R. (1973). Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. The Lancet, 301(7809), 897-904Barr, W. (1984). Pyridoxine supplements in the premenstrual syndrome. The Practitioner, 228(1390), 425Brush, M. G., Bennett, T., & Hansen, K. (1988). Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients. The British journal of clinical practice, 42(11), 448-452Brush MG. Vitamin B6 treatment of premenstrual syndrome. In: Leklem JE, Reynolds RD, eds. Clinical and physiological applications of vitamin B6. New York: Liss, 1988: 363-79. (Current topics in nutrition and disease, vol 19)Colin C. Studies on the treatment of mastalgia. Rev Med Brux 1982;3:605-9Day, J. B. (1979). Clinical trials in the premenstrual syndrome. Current Medical Research and Opinion, 6(sup5), 40-45De Souza, M. C., Walker, A. F., Robinson, P. A., & Bolland, K. (2000). A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. Journal of women's health & gender-based medicine, 9(2), 131-139Diegoli, M. S. C., Da Fonseca, A. M., Diegoli, C. A., & Pinotti, J. A. (1998). A double‐blind trial of four medications to treat severe premenstrual syndrome. International Journal of Gynecology & Obstetrics, 62(1), 63-67Doll, H., Brown, S., Thurston, A., & Vessey, M. (1989). Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. The Journal of the Royal College of General Practitioners, 39(326), 364-368Ebrahimi, E., Motlagh, S. K., Nemati, S., & Tavakoli, Z. (2012). Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms. Journal of caring sciences, 1(4), 183Fathizadeh, N., Ebrahimi, E., Valiani, M., Tavakoli, N., & Yar, M. H. (2010). Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iranian Journal of Nursing and Midwifery Research,15(Suppl1), 401Jia-li, C. (2011, December). Clinical observation about 40 cases of primary dysmenorrheal with the treatment of Marvelon & Vitamin B6. In 2011 IEEE International Symposium on IT in Medicine and Education (Vol. 1, pp. 517-519). IEEEKashanian, M., Mazinani, R., Jalalmanesh, S., & Babayanzad Ahari, S. (2007). Pyridoxine (vitamin B6) therapy for premenstrual syndrome. International Journal of Gynecology & Obstetrics, 96(1), 43-44Kendall, K. (1985). The effects of vitamin B6 supplementation on premenstrual symptomsKerr, G. D. (1977). The management of the premenstrual syndrome. Current Medical Research and Opinion, 4(sup4), 29-34Kiani, F., Sayehmiri, K., Sayehmiri, F., Naghdi, N., Ghafari, M., Asadi-Samani, M., & Bahmani, M. (2016). Effects of vitamin B6 on premenstrual syndrome: A systematic review and meta-Analysis. Journal of Chemical and Pharmaceutical Sciences, 9(3), 1346-1353Lauritzen, C. H., Reuter, H. D., Repges, R., Böhnert, K. J., & Schmidt, U. (1997). Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine,4(3), 183-189London, R. S., Bradley, L., & Chiamori, N. Y. (1991). Effect of a nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study. Journal of the American College of Nutrition, 10(5), 494-499Malmgren, R., Collins, A., & Nilsson, C. G. (1987). Platelet serotonin uptake and effects of vitamin B6-treatment in premenstrual tension. Neuropsychobiology,18(2), 83-88Masoumi, S. Z., Ataollahi, M., & Oshvandi, K. (2016). Effect of combined use of calcium and vitamin B6 on premenstrual syndrome symptoms: a randomized clinical trial. Journal of caring sciences, 5(1), 67Mattes, J. A., & Martin, D. (1982). Pyridoxine in premenstrual depression. Human nutrition: Applied nutritionMotesharee, E., Rahimi, E., Asadi, N., Jafari, M., & Mehbodi, M. (2013). Effects of Flexibility Exercise and Supplement Vitamin B6 on Primary Dysmenorrhea in Female Non-Athletes. Armaghane danesh,18(7), 509-519Montiel-Ruiz, R. M., González-Trujano, M. E., & Deciga-Campos, M. (2013). Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test. Phytomedicine, 20(14), 1280-1287Salehi, L., & Salehi, F. (2007). Comparative study of vitamin B6 versus placebo in premenstrual syndromeShaik, M. M., & Gan, S. H. (2015). Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed research international, 2015Sharma, P., Kulshreshtha, S., Singh, G. M., & Bhagoliwal, A. (2007). Role of bromocriptine and pyridoxine in premenstrual tension syndrome. Indian J Physiol Pharmacol, 51(4), 368-74Smallwood, J., Ah-Kye, D., & Taylor, I. (1986). Vitamin B6 in the treatment of pre-menstrual mastalgia. The British journal of clinical practice, 40(12), 532Stewart, A. (1987). Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. The Journal of reproductive medicine, 32(6), 435-441Stokes, J., & Mendels, J. (1972). Pyridoxine and premenstrual tension. Lancet (London, England), 1(7761), 1177Williams, M. J., Harris, R. I., & Dean, B. C. (1985). Controlled trial of pyridoxine in the premenstrual syndrome. Journal of international medical research, 13(3), 174-179Wyatt, K. M., Dimmock, P. W., Jones, P. W., & O'Brien, P. S. (1999). Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. Bmj, 318(7195), 1375-1381.Ranjana P Bird. (2018). The Emerging Role of Vitamin B6 in Inflammation and Carcinogenesis. National Library of Medicine.David O Kennedy. (2016). B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. National Library of Medicine.
Afficher plus
OFFERTO CON QUALSIASI CURA DI 2 O 3 MESI
IL METODO 28 GIORNI
Il nostro programma
🥑alimentazione
🧘♀️ gestione dello stress
🤸♀️ movimento
🗓️ 4 settimane
Per massimizzare l'efficacia delle cure e mantenere l'equilibrio.
